MedDataX Logo

Cost of Long Term Disability in Patients With Chronic Non-Specific Low Back Pain

NCT ID: NCT00652236

Last Updated: 2008-04-03

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

174 participants

Study Classification

OBSERVATIONAL

Study Start Date

2006-01-31

Study Completion Date

2008-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of the study was to determine the cost-effectiveness of a function-centred treatment (FCT) compared with a pain-centred treatment (PCT) in patients with chronic low back pain (LBP) in an in-patient setting. Follow-up lasted three years. Direct and indirect costs were recorded by questionnaires sent to health insurances, employers and Swiss Disability Insurance Company.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Low Back Pain

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Low back pain Economics Cost-effectiveness

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

FCT

Patients passing a function- centred rehabilitation

Physiotherapy

Intervention Type OTHER

The two groups passed an in-patient rehabilitation and a physiotherapy: FCT function-centred vs. PCT pain-centred

PCT

Patients passing a pain-centred rehabilitation

Physiotherapy

Intervention Type OTHER

The two groups passed an in-patient rehabilitation and a physiotherapy: FCT function-centred vs. PCT pain-centred

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Physiotherapy

The two groups passed an in-patient rehabilitation and a physiotherapy: FCT function-centred vs. PCT pain-centred

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Chronic low back pain, sick leave of 6 weeks during the last 6 months

Exclusion Criteria

* not able to perform a training program
Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Applied Sciences of Western Switzerland

OTHER

Sponsor Role collaborator

Zurich University of Applied Sciences

OTHER

Sponsor Role collaborator

Klinik Valens

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Rehabilitationszentrum Klinik Valens, CH- 7317 Valens

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Stefan Bachmann, MD

Role: PRINCIPAL_INVESTIGATOR

Rehabilitationszentrum Klinik Valens

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rehabilitationszentrum Klinik Valens

Valens, Canton of St. Gallen, Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

405340-111500

Identifier Type: -

Identifier Source: org_study_id